It is an undeniable fact that cancer prevention thrives on its early detection. Despite the therapeutic and technological advancement, 80 percent of cancers in low-and-middle-income countries are invariably detected at an advanced stage. Although a majority of cancer cases are detected in the age group of 45 to 60, we do find a growing (albeit not alarming as yet) incidence of breast cancer, nasopharyngeal cancer, and hematological malignancies in the age group of 20 to 40. In recent times, we are also seeing more cases of ovarian cancer in this age group.
There have been a lot of studies worldwide on this phenomenon. In this context, it is pertinent to note that the analysis done by HCG revealed that the mortality in the 16-40 age group was 14 percent, and the mortality in the 40 to 60 age group was 60 percent.
The analysis also revealed that the proportion of mortality was the highest in Bone and Soft tissue sarcoma cases in this age group. Notwithstanding the small proportion compared to adult populations, the current scenario is indeed a cause of concern.
The causes of the rise
So, why are we seeing a rise in cancer cases across all age groups? One school of thought says cancer was always prevalent, but as cancer detection was poor before, more cases are being reported in recent times. There is a fractional element of truth in that conjecture - given better community awareness, improving access to healthcare, and the pivotal role played by technological innovations that we see today - but it is not the principal reason for the rising number of cancer cases.
Diese Geschichte stammt aus der March 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der March 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.